Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

130.04 USD -0.48 (-0.37%)
Official Closing Price Updated: 4:21 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Exact Sciences Cor

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope
Talented team and industry-leading lab will help strengthen the company's sequencing and pipeline capabilities, while broadening its therapy selection and treatment guidance offerings 
From PR Newswire
Exact Sciences schedules first quarter 2021 earnings call
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its first quarter 2021 financial results after the close of the U.S. financial markets on May 4, 2021. Following... 
From PR Newswire
Exact Sciences to participate in March investor conferences
Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited investors to participate by webcast. 
From PR Newswire
Exact Sciences to Acquire Ashion Analytics and Enter Research Collaboration with City of Hope's Genomics Institute, TGen
Provides Access to Industry-Leading Sequencing Lab and Plans for 10-Year Partnership with National Cancer Research Leaders 
From PR Newswire
Exact Sciences Announces Fourth Quarter 2020 Results
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $466.3 million for the fourth quarter ended Dec. 31, 2020 and $1,491.4 million for the full year ended Dec. 31,... 
From PR Newswire
Thinking about trading options or stock in Nvidia, General Electric, Nio, EXACT Sciences, or Paypal?
InvestorsObserver issues critical PriceWatch Alerts for NVDA, GE, NIO, EXAS, and PYPL. 
From PR Newswire
Worldwide Tissue Diagnostics Industry to 2025 - Featuring Abbott Laboratories, Agilent Technologies & AstraZeneca Among Others - ResearchAndMarkets.com
The "Tissue Diagnostics Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. 
From Business Wire News Releases
Sema4 Appoints Isaac Ro, Life Sciences Executive and Wall Street Veteran, as Chief Financial Officer
Isaac Ro, life sciences executive and Wall Street veteran, joins Sema4 as Chief Financial Officer 
From Business Wire News Releases
Catalio Capital Management Launches Credit Opportunities Strategy
Catalio Capital Management, LP (Catalio), a multi-strategy life sciences investment firm, has today announced the launch of their Credit Opportunities strategy to expand the scope of the firm’s... 
From Business Wire News Releases
Exact Sciences schedules fourth quarter 2020 earnings call
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its fourth quarter 2020 financial results after the close of the U.S. financial markets on February 16, 2021.... 
From PR Newswire
Exact Sciences to participate in February investor conferences
Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participate by webcast. 
From PR Newswire
Exact Sciences Licenses Targeted Digital Sequencing Method to Extend Leadership in Precision Oncology
Worldwide Exclusive License Provides Access to Targeted Digital Sequencing (TARDIS) Blood Biopsy Method for Use in Minimal Residual Disease Testing 
From PR Newswire
New Prospective Data Demonstrate Low False-Positive Rate for Screening Average-Risk People Age 45-49 for Colorectal Cancer with Cologuard®
Cologuard's high specificity would help minimize risk and cost from unnecessary diagnostic procedures in this age group 
From PR Newswire
Should you invest in Exxon Mobil, Wells Fargo, General Motors, Etsy, or EXACT Sciences?
InvestorsObserver issues critical PriceWatch Alerts for XOM, WFC, GM, ETSY, and EXAS. 
From PR Newswire
Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
- Expected total revenue of $464.5-467.5M, including Screening revenue of $249-250M, Precision Oncology revenue of $117-118M, and COVID-19 testing revenue of $98.5-99.5M 
From PR Newswire
Exact Sciences Completes Acquisition of Thrive Earlier Detection, Creating a Leader in Blood-Based, Multi-Cancer Screening
Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has completed its previously announced acquisition of Thrive Earlier Detection Corp. ("Thrive"). 
From PR Newswire
Exact Sciences to participate in J.P. Morgan Healthcare Conference
Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participate by webcast. 
From PR Newswire
Cognitive Assessment & Training in Healthcare Market Could Reach $45 Billion by 2026
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cognitive Assessment & Training in Healthcare Market Could Reach $45 Billion by 2026
Financialnewsmedia.com News Commentary 
From PR Newswire
New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score® Test in Shaping Clinical Practice
- Five-year outcomes from large, prospective phase III ADAPT study confirm value of the test to help guide treatment decisions in breast cancer patients with high clinical risk, including those with... 
From PR Newswire
RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer
Exact Sciences Corp. (NASDAQ: EXAS) today announced that data from the Rx for Positive Node, Endocrine Responsive Breast Cancer, or RxPONDER, trial successfully defined the benefit of chemotherapy in... 
From PR Newswire
Exact Sciences to participate in December investor conference
Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors to participate by webcast. 
From PR Newswire
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes. 
From PR Newswire
Exact Sciences to participate in November investor conferences
Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participate by webcast. 
From PR Newswire
Thinking about buying stock in Apple, Titan Pharmaceuticals, Tupperware Brands, EXACT Sciences, or Roku?
InvestorsObserver issues critical PriceWatch Alerts for AAPL, TTNP, TUP, EXAS, and ROKU. 
From PR Newswire
Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45
Cologuard® remains a recommended screening method in the draft 
From PR Newswire
Thinking about buying stock in Xilinx, General Electric, EXACT Sciences, Harley-Davidson, or American International?
InvestorsObserver issues critical PriceWatch Alerts for XLNX, GE, EXAS, HOG, and AIG. 
From PR Newswire
Exact Sciences Announces Entry into Agreements to Sell $869 Million of Common Stock in Registered Direct Offering
Exact Sciences Corporation (Nasdaq: EXAS) today announced the entry into agreements to sell an aggregate of 8,605,483 shares (the "Shares") of its common stock, par value $0.01 per share, in a... 
From PR Newswire
Exact Sciences Announces Third Quarter 2020 Results
Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $408.4 million for the third quarter ended September 30, 2020, compared to $218.8 million for the same period... 
From PR Newswire
Exact Sciences To Acquire Thrive Earlier Detection, Becoming A Leader In Blood-Based, Multi-Cancer Screening
Brings Together Cancer Screening R&D Pioneers to Transform the Future of Cancer Diagnostics and Impact Lives 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback